ESC 365 - Response to cardiac resynchronization therapy with quadripolar lead - preliminary results of ResQ-CRT prospective study

ESC Premium Access

Response to cardiac resynchronization therapy with quadripolar lead - preliminary results of ResQ-CRT prospective study

Session: Clinical results in CRT: patient groups, leads and optimisation

Topic: Resynchronisation therapy

Speaker: Doctor A. Vado (Turin, IT)

Event: ESC Congress 2016

Congress Presentation

Add to my library

About the speaker

Doctor Antonello Vado

Maria Pia Hospital, Turin (Italy)

0 follower

9 more presentations in this session

Effects of upgrade versus de-novo cardiac resynchronization therapy on clinical response and long-term survival: Results form a large multicenter study

Speaker: Doctor M. Vamos (Szeged, HU)

A novel algorithm increases effective left ventricular pacing during atrial fibrillation in patients undergoing cardiac resynchronization therapy: primary results of the randomized CRTee trial

Speaker: Doctor S. Mittal (Ridgewood, US)

Early AV node ablation versus pharmacological rate control in patients with CRT and AF. Results of SPARE III, a randomized multicenter study.

Speaker: Doctor M. Trucco (Girona, ES)

Cardiac resynchronization therapy defibrillator at the end of battery life; is time to discuss the need to re-implant a device with defibrillator back-up in all patients?

Speaker: Doctor R. Rordorf (Pavia, IT)

Device-related infective endocarditis in cardiac resynchronization therapy recipients - single center registry with over 2500 person-years follow up

Speaker: Mrs E. Jedrzejczyk-Patej (Zabrze, PL)

Access the full session

Clinical results in CRT: patient groups, leads and optimisation

Speakers: Doctor A. Vado, Doctor M. Vamos, Doctor S. Mittal, Doctor M. Trucco, Doctor R. Rordorf...

About the event

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources